SL

Simulations Plus, Inc.

SLPHealthcareNASDAQ

Health Information Services · Last scanned Sep 7, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$79.2M
+13.1% YoY
Net Income
-$64.7M
-750.2% YoY
EBITDA
$14.7M
+24.6% YoY
Free Cash Flow
$18.4M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 RSI OverboughtRSI 80.0, above 70, stock may be overbought
Sep 2 RSI OverboughtRSI 75.0, above 70, stock may be overbought
About Simulations Plus, Inc.

Part of the healthcare sector, Simulations Plus, Inc. (SLP) is listed under Health Information Services. At a $372.7M market cap, Simulations Plus, Inc. ranks as a small-cap company within healthcare. It operates through Software and Services segments.

Where SLP stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, SLP finished 18.98% above its 150-day moving average ($15.49) and 12.86% above its 200-day moving average ($16.33). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is SLP overbought or oversold?

At the September 3, 2026 close, SLP's RSI(14) was 80.0, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$372.7M
P/E (TTM)46.08
Fwd P/E20.88
EPS$0.40
Beta1.33
52W Change+30.2%
ROE6.2%
Analysis

Simulations Plus, Inc. holds $50.0M in cash against $487K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $18.4M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 6.2%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $53.9M (2022) to $79.2M (2025), reflecting a 47% increase over the period.

With cash comfortably exceeding debt, SLP has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Simulations Plus, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms